156 related articles for article (PubMed ID: 18722100)
1. Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study.
Lamprecht B; Schirnhofer L; Kaiser B; Buist S; Studnicka M
Respir Med; 2008 Dec; 102(12):1833-8. PubMed ID: 18722100
[TBL] [Abstract][Full Text] [Related]
2. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
[TBL] [Abstract][Full Text] [Related]
4. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey.
Celli BR; Halbert RJ; Nordyke RJ; Schau B
Am J Med; 2005 Dec; 118(12):1364-72. PubMed ID: 16378780
[TBL] [Abstract][Full Text] [Related]
5. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
6. COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies.
Hagstad S; Ekerljung L; Lindberg A; Backman H; Rönmark E; Lundbäck B
Respir Med; 2012 Jul; 106(7):980-8. PubMed ID: 22498109
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
[TBL] [Abstract][Full Text] [Related]
8. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.
Swanney MP; Ruppel G; Enright PL; Pedersen OF; Crapo RO; Miller MR; Jensen RL; Falaschetti E; Schouten JP; Hankinson JL; Stocks J; Quanjer PH
Thorax; 2008 Dec; 63(12):1046-51. PubMed ID: 18786983
[TBL] [Abstract][Full Text] [Related]
9. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].
Geldmacher H; Biller H; Herbst A; Urbanski K; Allison M; Buist AS; Hohlfeld JM; Welte T
Dtsch Med Wochenschr; 2008 Dec; 133(50):2609-14. PubMed ID: 19052996
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old.
Geijer RM; Sachs AP; Hoes AW; Salomé PL; Lammers JW; Verheij TJ
Fam Pract; 2005 Oct; 22(5):485-9. PubMed ID: 15964866
[TBL] [Abstract][Full Text] [Related]
11. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
[TBL] [Abstract][Full Text] [Related]
12. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of COPD in Iceland--the BOLD study].
Benediktsdóttir B; Gudmundsson G; Jörundsdóttir KB; Vollmer W; Gíslason T
Laeknabladid; 2007 Jun; 93(6):471-7. PubMed ID: 17541146
[TBL] [Abstract][Full Text] [Related]
14. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
[TBL] [Abstract][Full Text] [Related]
15. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
[TBL] [Abstract][Full Text] [Related]
16. Six-second spirometry for detection of airway obstruction: a population-based study in Austria.
Lamprecht B; Schirnhofer L; Tiefenbacher F; Kaiser B; Buist SA; Studnicka M; Enright P
Am J Respir Crit Care Med; 2007 Sep; 176(5):460-4. PubMed ID: 17556719
[TBL] [Abstract][Full Text] [Related]
17. COPD 'diagnosis' based on spirometric reference equations.
Olofson J; Bake B; Tengelin MN; Houltz B
Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
[TBL] [Abstract][Full Text] [Related]
18. Gender and chronic obstructive pulmonary disease in high-risk smokers.
de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
[TBL] [Abstract][Full Text] [Related]
19. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
[TBL] [Abstract][Full Text] [Related]
20. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
